Drug Discovery & Screening
(150 products)
Reliable preclinical results start with the right cell model. This collection brings together over 150 primary cells, non-tumor continuous lines, and subcellular fractions spanning human, mouse, rat, and several other species — covering tissues from lung and intestine to skin, brain, kidney, and beyond. These cells are used across target identification, hit-to-lead screening, permeability assays, and early safety profiling. For tumor-specific screening models, see the tumor cell lines collection.
